MA52960A - Compositions et procédés pour la réduction ou le traitement de la fibrose - Google Patents

Compositions et procédés pour la réduction ou le traitement de la fibrose

Info

Publication number
MA52960A
MA52960A MA052960A MA52960A MA52960A MA 52960 A MA52960 A MA 52960A MA 052960 A MA052960 A MA 052960A MA 52960 A MA52960 A MA 52960A MA 52960 A MA52960 A MA 52960A
Authority
MA
Morocco
Prior art keywords
fibrosis
compositions
reduction
treatment
methods
Prior art date
Application number
MA052960A
Other languages
English (en)
French (fr)
Inventor
Raffi Afeyan
Nadine Daou
Michael Hamill
Luke S Hamm
Chung-Wei Lee
Harry Luithardt
Svetlana Marukian
Original Assignee
Axcella Health Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Axcella Health Inc filed Critical Axcella Health Inc
Publication of MA52960A publication Critical patent/MA52960A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Neurology (AREA)
  • Nutrition Science (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
MA052960A 2018-06-20 2019-06-19 Compositions et procédés pour la réduction ou le traitement de la fibrose MA52960A (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862687718P 2018-06-20 2018-06-20
US201862758174P 2018-11-09 2018-11-09
US201962794154P 2019-01-18 2019-01-18

Publications (1)

Publication Number Publication Date
MA52960A true MA52960A (fr) 2021-04-28

Family

ID=67253997

Family Applications (1)

Application Number Title Priority Date Filing Date
MA052960A MA52960A (fr) 2018-06-20 2019-06-19 Compositions et procédés pour la réduction ou le traitement de la fibrose

Country Status (6)

Country Link
US (1) US20210275480A1 (https=)
EP (1) EP3810272A1 (https=)
JP (1) JP2021527669A (https=)
CN (1) CN112839708A (https=)
MA (1) MA52960A (https=)
WO (1) WO2019246298A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
CN112823018A (zh) 2018-06-20 2021-05-18 胺细拉健康公司 制备氨基酸组合物的方法
WO2023009444A1 (en) * 2021-07-26 2023-02-02 Axcella Health Inc. Amino acid compositions and methods for use in the treatment of post-acute sequelae of covid-19

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070286909A1 (en) * 2006-06-07 2007-12-13 Daniel S. Smith Amino acid compositions
US9884899B2 (en) * 2007-07-06 2018-02-06 Promedior, Inc. Methods for treating fibrosis using CRP antagonists
KR20090028880A (ko) * 2007-09-17 2009-03-20 재단법인서울대학교산학협력재단 섬유증 예방 또는 치료용 약제학적 조성물
US20150080320A1 (en) * 2012-05-16 2015-03-19 Aadigen, Llc Multi-target modulation for treating fibrosis and inflammatory conditions
WO2015061607A1 (en) * 2013-10-23 2015-04-30 Whitehead Institute For Biomedical Research Mtorc1 modulation by amino acids and uses thereof

Also Published As

Publication number Publication date
EP3810272A1 (en) 2021-04-28
US20210275480A1 (en) 2021-09-09
WO2019246298A1 (en) 2019-12-26
JP2021527669A (ja) 2021-10-14
CN112839708A (zh) 2021-05-25

Similar Documents

Publication Publication Date Title
EP3947715A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER
EP3894392A4 (en) COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER
EP3612215A4 (en) COMPOSITIONS AND METHODS OF TREATMENT OF Pneumonia
MA53873A (fr) Compositions et procédés pour le traitement de la presbytie
EP3630072A4 (en) METHODS AND COMPOSITIONS FOR TREATMENT OF EXCESSIVE Drowsiness
EP3645739A4 (en) METHODS AND COMPOSITIONS FOR TREATMENT OF MELANOMA
MA51103A (fr) Compositions et procédés de traitement de l'atrophie musculaire et de la dystrophie myotonique
MA51306A (fr) Compositions et procédés améliorés pour le traitement du déficit en ornithine transcarbamylase
MA51739A (fr) Compositions pharmaceutiques pour le traitement de la fibrose kystique
EP3555077A4 (en) COMPOSITIONS AND METHODS OF TREATMENT OF CANCER
MA50849A (fr) Substances et procédés pour le traitement d'hémoglobinopathies
MA71705A (fr) Substances et procédés pour le traitement d'hémoglobinopathies
EP3341391A4 (en) COMPOSITIONS AND METHODS OF PAIN TREATMENT
EP3481387A4 (en) METHOD AND COMPOSITIONS FOR TREATING EPILEPTIC DISEASES
EP3781214A4 (en) Compositions and methods for treating spinal muscular atrophy
EP3390642A4 (en) COMPOSITIONS AND METHODS OF TREATING RETINITIS PIGMENTOSA 18 AND RETINITIS PIGMENTOSA 13
EP3833340A4 (en) COMPOSITIONS AND METHODS OF TREATMENT FOR PRESBYOPIA
EP3448421A4 (en) METHOD AND COMPOSITIONS FOR PREVENTING AND TREATING SURGICAL ADHESIVES
EP3735325A4 (en) SURFACE TREATMENT COMPOSITIONS AND PROCEDURES
EP3908601A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER
MA52961A (fr) Compositions et procédés pour la réduction ou le traitement d'une inflammation
EP3429609A4 (en) COMPOSITIONS AND METHOD FOR TREATING DEFECTS OF COLLAGEN TYPE VII
EP3830196A4 (en) SURFACE TREATMENT COMPOSITIONS AND PROCEDURES
EP3405172A4 (en) METHOD AND COMPOSITIONS FOR THE TREATMENT OF AGED SKIN
EP4017924A4 (en) SURFACE TREATMENT COMPOSITIONS AND METHODS